老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

63.67
-2.0800-3.16%
成交量：92.35万
成交额：5,951.19万
市值：124.67亿
市盈率：-17.84
高：66.05
开：66.05
低：63.57
收：65.75
52周最高：93.42
52周最低：52.75
股本：1.96亿
流通股本：1.67亿
量比：0.84
换手率：0.55%
股息：- -
股息率：- -
每股收益(TTM):-3.5686
每股收益(LYR):-3.7850
净资产收益率：-1789.67%
总资产收益率：-26.00%
市净率：-4.96
市盈率(LYR):-16.82

数据加载中...

总览公司新闻资讯公告
2020/03/04

重要事件披露

Current report, item 8.01
2020/03/03

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/02

重要事件披露

Current report, items 2.02 and 9.01
2020/02/19

重要事件披露

Current report, item 5.02
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/07

重要事件披露

Current report, item 1.01
2019/12/26

重要事件披露

Current report, items 2.02 and 9.01
2019/12/17

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/11/20

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/11/19

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/15

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/11

重要事件披露

Current report, item 5.02
2019/09/12

重要事件披露

Current report, items 1.01, 7.01, and 9.01
2019/08/14

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/08

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/11

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/07/10

超过5%披露

General statement of acquisition of beneficial ownership
更多